These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 137765)
21. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy. Lance JW; Anthony M Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689 [No Abstract] [Full Text] [Related]
22. [The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note]. Piccinin GL; Morocutti C; Urciuoli R; Bernardi G Clin Ter; 1977 Jul; 82(1):25-30. PubMed ID: 332440 [No Abstract] [Full Text] [Related]
23. [Proposal for the introduction of a new substance into hospital practice: dipropyl acetate sodium in the prevention and treatment of alcoholic delirium]. Bonfiglio G; Falli S; Pacini A Minerva Med; 1977 Dec; 68(63):4233-45. PubMed ID: 340985 [TBL] [Abstract][Full Text] [Related]
24. Early experience with sodium valproate. Ancamp AK; Joubert PH S Afr Med J; 1977 Feb; 51(9):260. PubMed ID: 322329 [No Abstract] [Full Text] [Related]
25. Sodium valproate (Epilim) in the treatment of refractory epilepsy. Lines DR N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342 [TBL] [Abstract][Full Text] [Related]
28. A syndrome from a possible GABA deficiency. Clinical-therapeutic report on 15 cases. Cocchi R Acta Psychiatr Belg; 1978; 78(2):407-24. PubMed ID: 354328 [TBL] [Abstract][Full Text] [Related]
30. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study]. Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058 [No Abstract] [Full Text] [Related]
31. Isoniazid and Huntington's chorea. Perry TL N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007 [No Abstract] [Full Text] [Related]
32. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value? Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619 [No Abstract] [Full Text] [Related]
33. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy]. Trompetter-van Woerden ML; van der Zwan A Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732 [No Abstract] [Full Text] [Related]
38. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain. Kukino K; Deguchi T Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2257-62. PubMed ID: 338171 [No Abstract] [Full Text] [Related]
39. The use of sodium valproate in a case of status epilepticus. Barnes SE; Bland D; Cole AP; Evans AR Dev Med Child Neurol; 1976 Apr; 18(2):236-8. PubMed ID: 776731 [TBL] [Abstract][Full Text] [Related]
40. [Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)]. Raevskiĭ KS; Aleksandrovskiĭ IuA; Poiurovskiĭ MV; Kharlamov AN; Neznamov GG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):574-9. PubMed ID: 2860764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]